BFG
Bleakley Financial Group Portfolio holdings
AUM
$3.94B
This Quarter Return
+10.32%
1 Year Return
+21.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.15B
AUM Growth
+$3.15B
(+11%)
Cap. Flow
+$52.5M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
27.65%
Holding
995
New
110
Increased
428
Reduced
383
Closed
45
Top Buys
| 1 |
Vanguard FTSE Pacific ETF
VPL
|
$16M |
| 2 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$15.9M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$7.16M |
| 4 |
iShares Silver Trust
SLV
|
$6.38M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$4.95M |
Top Sells
Sector Composition
| 1 | Technology | 12.59% |
| 2 | Healthcare | 10.68% |
| 3 | Financials | 5.58% |
| 4 | Consumer Discretionary | 4.96% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
ADMA Biologics
ADMA
$4.1B
| $46.8K | ﹤0.01% |
10,355
-103
| -1% | -$466 |
|
927
NextNav
NN
$2.34B
| $46.2K | ﹤0.01% |
10,384
+123
| +1% | +$547 |
|
928
Compass
COMP
$4.7B
| $46.2K | ﹤0.01% |
12,282
+695
| +6% | +$2.61K |
|
929
Olaplex Holdings
OLPX
$947M
| $46K | ﹤0.01% |
+18,118
| New | +$46K |
|
930
Precigen
PGEN
$1.42B
| $45.9K | ﹤0.01% |
34,245
-10,731
| -24% | -$14.4K |
|
931
SCYNEXIS
SCYX
$35M
| $44.6K | ﹤0.01% |
20,000
| – | – |
|
932
Fate Therapeutics
FATE
$119M
| $41.2K | ﹤0.01% |
11,003
-1,009
| -8% | -$3.77K |
|
933
FingerMotion
FNGR
$91.5M
| $40.2K | ﹤0.01% |
+10,000
| New | +$40.2K |
|
934
GoPro
GPRO
$236M
| $34.7K | ﹤0.01% |
10,006
-2,678
| -21% | -$9.29K |
|
935
Karyopharm Therapeutics
KPTI
$58.8M
| $32.8K | ﹤0.01% |
+37,938
| New | +$32.8K |
|
936
Energy Vault
NRGV
$340M
| $32.7K | ﹤0.01% |
+14,042
| New | +$32.7K |
|
937
Tilray
TLRY
$1.37B
| $30.8K | ﹤0.01% |
13,380
-89
| -0.7% | -$205 |
|
938
Planet Labs
PL
$2.02B
| $27.8K | ﹤0.01% |
+11,237
| New | +$27.8K |
|
|
CTEV
939
Claritev Corporation
CTEV
$1.14B
| $25.9K | ﹤0.01% |
18,007
+95
| +0.5% | +$137 |
|
940
Gannett
GCI
$592M
| $23.1K | ﹤0.01% |
10,036
-599
| -6% | -$1.38K |
|
941
Ginkgo Bioworks
DNA
$652M
| $22.5K | ﹤0.01% |
13,298
+2,977
| +29% | +$5.03K |
|
942
SoundHound AI
SOUN
$5.47B
| $21.4K | ﹤0.01% |
10,094
-25,327
| -72% | -$53.7K |
|
943
Pyxis Oncology
PYXS
$82.5M
| $20.2K | ﹤0.01% |
11,234
| – | – |
|
944
SelectQuote
SLQT
$373M
| $16K | ﹤0.01% |
11,699
+729
| +7% | +$999 |
|
945
Matinas BioPharma
MTNB
$10.2M
| $13K | ﹤0.01% |
60,016
| – | – |
|
946
Clover Health Investments
CLOV
$1.38B
| $10.5K | ﹤0.01% |
11,074
| – | – |
|
|
MMAT
947
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $3.38K | ﹤0.01% |
51,200
| – | – |
|
|
BHIL
948
DELISTED
Benson Hill, Inc.
BHIL
| $2.41K | ﹤0.01% |
+13,887
| New | +$2.41K |
|
|
CRGE
949
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $2.35K | ﹤0.01% |
20,555
| – | – |
|
950
Alaunos Therapeutics
TCRT
$4.51M
| $1.01K | ﹤0.01% |
14,250
| – | – |
|